There are 2+ publications for this product available. The Mouse Monoclonal anti-AGT antibody is suitable to detect AGT in samples from Human. It has been validated for WB and ELISA.
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage
4 °C,-20 °C
Storage Comment
Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.
Xu, Carretero, Lin, Cavasin, Shesely, Yang, Reudelhuber, Yang: "Role of cardiac overexpression of ANG II in the regulation of cardiac function and remodeling postmyocardial infarction." in: American journal of physiology. Heart and circulatory physiology, Vol. 293, Issue 3, pp. H1900-7, (2007) (PubMed).
Rossi, Zappa, Ferraresi, Santiemma: "Adrenomedullin inhibits angiotensin II-induced contraction in human aortic smooth muscle cells." in: Regulatory peptides, Vol. 133, Issue 1-3, pp. 155-9, (2005) (PubMed).
Target
AGT
(Angiotensinogen (serpin Peptidase Inhibitor, Clade A, Member 8) (AGT))
Alternative Name
AGT
Background
AGT, pre-angiotensinogen or angiotensinogen precursor, is expressed in the liver and is cleaved by the enzyme renin in response to lowered blood pressure. The resulting product, angiotensin I, is then cleaved by angiotensin converting enzyme (ACE) to generate the physiologically active enzyme angiotensin II. The protein is involved in maintaining blood pressure and in the pathogenesis of essential hypertension and preeclampsia. Mutations in this gene are associated with susceptibility to essential hypertension, and can cause renal tubular dysgenesis, a severe disorder of renal tubular development. Defects in this gene have also been associated with non-familial structural atrial fibrillation, and inflammatory bowel disease.